Tovorafenib for treating relapsed or refractory paediatric low-grade glioma with BRAF fusion or rearrangement or BRAF V600 mutation in people 6 months and over [ID6557]

  • In development
  • GID-TA11693
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6557